KEY WORDS | Gene Editing, Trans-Splicing, Neurodegenerative Diseases |
CITY | Fontenay-aux-Roses |
COUNTRY | France |
DETAILS OF THE OFFER | Working place: Laboratory of Neurodegenerative Diseases at CEA Fontenay-aux-Roses within the "Cellular Interactions: Models and Biotherapies" team Work Context: Focused on the study of Alzheimer's, Parkinson's, and Huntington's diseases, the laboratory has all the infrastructure to conduct experimental gene therapy projects, from the design of gene transfer tools to the proof of concept of their therapeutic efficacy in animal models. The laboratory also has its own AAV and lentiviral vector production platform. As part of a project funded by the PEPR Biotherapy and Bioproduction of Innovative Therapies, we are seeking a post-doctoral researcher to implement a transcriptome editing strategy for genetically originated neurodegenerative diseases. We have previously demonstrated the potential of this technology in diverse pathological contexts. Missions: Post-doctoral Researcher (M/F), fixed-term contract of 12 months, renewable, to establish a screening platform for rapidly isolating candidate RNAs for therapeutic targeting of mRNA by trans-splicing (SMaRT technology, Spliceosome-mediated RNA trans-splicing). This platform will be obtained through the combination of cellular tools (reporter cell lines) and molecular tools (candidate RNA libraries) that the researcher will be responsible for designing and constructing. He/she will benefit from the entire scientific environment of the Laboratory of Neurodegenerative Diseases, as well as technical support from the team responsible for viral production. The project will combine a wide range of molecular biology approaches (construction, high-throughput sequencing...) and cell biology (clone production, cell sorting by flow cytometry...). The selected person will be required to:
Qualifiactions:
|
TYPE OF JOB | Postdoc position |
TYPE OF CONTRACT | CDD (Temporary / 12 months, renewable) |
EMPLOYMENT START DATE | ASAP |